ASGCT Highlights Use of Living Human Cells in Treating Cancer and Genetic Disorders

The American Society of Gene and Cell Therapy (ASGCT) defines cell therapy as a medical approach that involves administering living human cells—either unmodified or genetically altered—to patients for the treatment of various diseases. This therapeutic method uses intact, viable cells with the potential to repair, replace, or regenerate damaged tissues and organs.

Cell therapy has gained attention for its application in addressing a range of conditions, including cancer, genetic disorders, and autoimmune diseases. The process involves harvesting cells from donors or patients themselves, modifying them if necessary to enhance their therapeutic properties, and reintroducing them into the body. As this field evolves, advancements in manufacturing processes are playing a critical role in scaling up production while maintaining safety and efficacy standards. These developments aim to meet growing demand and improve accessibility to these innovative treatments.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: January 27, 2025

Related posts:

CDMO Partnerships Streamline Pharma Operations, Accelerate Product Development from Concept to Market Indoco Remedies Gains USFDA Approval for Allopurinol Tablets USP 200 mg to Address Hyperuricemia New Study Identifies Long Noncoding RNA as Prognostic Biomarker and Therapeutic Target for Prostate Cancer FDA Grants Priority Review to Sevabertinib for HER2-Mutated Advanced NSCLC in Previously Treated Patients

Author

Mark Chiang